DSM to acquire Twilmij to strengthen position in Animal Nutrition & Health

8720feaa-a8a5-4aca-8a67-09ec8307b22farticleimage.jpg

22 Sep 2017 --- Royal DSM, a global science-based company active in health, nutrition and materials, has announced the acquisition of Twilmij B.V., a well-established Dutch nutritional solutions company in the animal feed sector. DSM notes that its strategy in Animal Nutrition & Health is to offer tailor-made solutions to its customers leveraging its product portfolio and innovation capabilities. 

With the acquisition of Twilmij, DSM will further strengthen its foothold in the Northwest-European markets. The geographic location in the middle of the Netherlands and close to the German border brings DSM closer to its customers and allows it to further improve its service levels.

Since its inception in 1963, Twilmij has successfully grown its business to net sales of approximately €70 million (US$84 million), which equates to 50,000 tons of premix production, in 2016.

Twilmij is recognized by its customers and other stakeholders as an outstanding partner due to its excellent nutritional services, speed and agility, DSM reports. The acquisition also includes Twilmij’s affiliated company Kwalipak B.V. which offers specialty small-pack solutions for specific applications for the feed industry. 

Financial details will not be disclosed at this time. Subject to customary conditions, the transaction is expected to close in the next two to three months.

RELATED ARTICLES
Homepicture

Algaia receives €4 million boost for seaweed extract production unit

22 May 2018 French biomarine company Algaia is to install a ...

Homepicture

Probiotics: Scientists investigate how seaweed can give a dietary boost to gut bacteria

11 May 2018 US researchers examining how to manipulate gut ...

Homepicture

Nexira enters strategic partnership for nutritionals, not giving up its acquisition plans

02 May 2018 Nexira, a global leader in natural and organic ...

Homepicture

DSM benefits from high vitamin prices in Q1, raises outlook

12 Apr 2018 DSM has pre-announced better-than-expected ...

Homepicture

Clinical merger: Novartis acquires AveXis for US$8.7bn, expands in gene therapy

09 Apr 2018 Novartis has entered into an agreement and plan ...